Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-14-009233
Filing Date
2014-12-31
Accepted
2014-12-31 11:33:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS f424b3123014_relmada.htm 424B3 2599259
  Complete submission text file 0001213900-14-009233.txt   2600311
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-197109 | Film No.: 141317728
SIC: 2834 Pharmaceutical Preparations